ATC Group: J05AR21 Dolutegravir and rilpivirine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J05AR21 in the ATC hierarchy

Level	Code	Title
1	J	Antiinfectives for systemic use
2	J05	Antivirals for systemic use
3	J05A	Direct acting antivirals
4	J05AR	Antivirals for treatment of HIV infections, combinations
5	J05AR21	Dolutegravir and rilpivirine

Active ingredients in J05AR21

Active Ingredient	Description
Dolutegravir and Rilpivirine

Related product monographs

Title	Information Source	Document Type
DALIDUO Film-coated tablet	Health Products Regulatory Authority (ZA)	MPI, Generic
JULUCA Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicines in this ATC group

United States (US)

(combination) JULUCA

Australia (AU)

(combination) JULUCA

Austria (AT)

(combination) JULUCA

Canada (CA)

(combination) JULUCA

Croatia (HR)

(combination) JULUCA

Cyprus (CY)

(combination) JULUCA

Ecuador (EC)

(combination) JULUCA

Estonia (EE)

(combination) JULUCA

Finland (FI)

(combination) JULUCA

France (FR)

(combination) JULUCA

Hong Kong (HK)

(combination) JULUCA

Ireland (IE)

(combination) JULUCA

Israel (IL)

(combination) JULUCA

Italy (IT)

(combination) JULUCA

Japan (JP)

(combination) JULUCA

Lithuania (LT)

(combination) JULUCA

Netherlands (NL)

(combination) JULUCA

New Zealand (NZ)

(combination) JULUCA

Poland (PL)

(combination) JULUCA

Romania (RO)

(combination) JULUCA

Singapore (SG)

(combination) JULUCA

South Africa (ZA)

(combination) DALIDUO
(combination) DALIVINE

Spain (ES)

(combination) JULUCA

Turkey (TR)

(combination) JULUCA

United Kingdom (UK)

(combination) JULUCA

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

Go to ATC index